6.6 C
London
Thursday, December 26, 2024
Subscribe
Home Tags LEQEMBI

Tag: LEQEMBI

“LEQEMBI” (Lecanemab) Approved for the Treatment of Early Alzheimer’s Disease in Mexico
Business

“LEQEMBI” (Lecanemab) Approved for the Treatment of Early Alzheimer’s Disease in Mexico

Editor -
0
Japan – “LEQEMBI” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in South Korea
Business

Japan – “LEQEMBI” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in South Korea

Leslie Atkins -
0
Japan – Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain
Business

Japan – Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain

-
0
Japan – “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in the United Arab Emirates
Business

Japan – “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in the United Arab Emirates

-
0
Japan – “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Israel
Business

Japan – “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Israel

Editor -
0
Japan – “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
Business

Japan – “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong

-
0
Japan – “LEQEMBI” Lecanemab) Approved for the Treatment of Alzheimer’s Disease in South Korea
Business

Japan – “LEQEMBI” Lecanemab) Approved for the Treatment of Alzheimer’s Disease in South Korea

-
0
Eisai: “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in China
Business

Eisai: “LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in China

-
0
Japan – “LEQEMBI Intravenous Infusion”Lecanemab) for the Treatment of Alzheimer’s Disease to be Launched in Japan on December 20
Business

Japan – “LEQEMBI Intravenous Infusion”Lecanemab) for the Treatment of Alzheimer’s Disease to be Launched in Japan on December 20

-
0
LEQEMBI Wins Best New Drug And Clinical Advance of The Year at The Scrip Awards 2023
Business

LEQEMBI Wins Best New Drug And Clinical Advance of The Year at The Scrip Awards 2023

-
0
Japan – LEQEMBI (lecanemab-Irmb) Named One of Time’s Best Inventions of 2023
Business

Japan – LEQEMBI (lecanemab-Irmb) Named One of Time’s Best Inventions of 2023

-
0
Japan – “LEQEMBI Intravenous Infusion” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan
Business

Japan – “LEQEMBI Intravenous Infusion” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan

-
0
© Newspaper WordPress Theme by TagDiv